Literature DB >> 26572789

Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma.

Atsushi Kobayashi1, Toshimi Kaido2, Yuhei Hamaguchi1, Shinya Okumura1, Kojiro Taura1, Etsuro Hatano1, Hideaki Okajima1, Shinji Uemoto1.   

Abstract

BACKGROUND: We have reported that preoperative low skeletal muscle quality was an independent risk factor for poor outcomes after hepatectomy for hepatocellular carcinoma (HCC). However, postoperative changes of quality as well as quantity of skeletal muscle after hepatectomy for HCC and their impact on postoperative outcomes have not been fully investigated.
METHODS: We retrospectively analyzed 241 patients undergoing primary hepatectomy for HCC between January 2007 and September 2012. The quality and quantity of skeletal muscle were evaluated by intramuscular adipose tissue content (IMAC) and the psoas muscle mass index (PMI) using computed tomography imaging at the umbilical level, respectively. We evaluated postoperative changes in IMAC and PMI in patients according to preoperative sarcopenia, sex, and surgical procedure. We also investigated the impact of ΔIMAC and ΔPMI on HCC recurrence in patients with preoperative normal IMAC.
RESULTS: On multivariate analysis, indocyanine green retention test at 15 min ≥ 15% (odds ratio [OR] = 3.156; P = 0.041) and high ΔIMAC at 6 months after hepatectomy (OR = 3.713; P = 0.024) were the risk factors for HCC recurrence in patients with preoperative normal IMAC.
CONCLUSION: Postoperative depletion of skeletal muscle quality is closely involved with HCC recurrence after hepatectomy for HCC.
© 2015 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Hepatocellular carcinoma; Intramuscular adipose tissue content; Psoas muscle mass index; Sarcopenia

Mesh:

Year:  2015        PMID: 26572789     DOI: 10.1002/jhbp.302

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  14 in total

1.  Postoperative Skeletal Muscle Loss Predicts Poor Prognosis of Adenocarcinoma of Upper Stomach and Esophagogastric Junction.

Authors:  Kensuke Kudou; Hiroshi Saeki; Yuichiro Nakashima; Koichi Kimura; Koji Ando; Eiji Oki; Tetsuo Ikeda; Yoshihiko Maehara
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

2.  Is sarcopenia a prognostic factor after living donor liver transplantation?

Authors:  Akira Umemura; Takeshi Takahara; Hiroyuki Nitta; Yasushi Hasegawa; Akira Sasaki
Journal:  Hepatobiliary Surg Nutr       Date:  2017-08       Impact factor: 7.293

3.  Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy.

Authors:  Hiroki Nishikawa; Norihiro Nishijima; Hirayuki Enomoto; Azusa Sakamoto; Akihiro Nasu; Hideyuki Komekado; Takashi Nishimura; Ryuichi Kita; Toru Kimura; Hiroko Iijima; Shuhei Nishiguchi; Yukio Osaki
Journal:  Oncol Lett       Date:  2017-05-31       Impact factor: 2.967

4.  Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.

Authors:  Atsushi Kobayashi; Toshimi Kaido; Yuhei Hamaguchi; Shinya Okumura; Hisaya Shirai; Naoko Kamo; Shintaro Yagi; Kojiro Taura; Hideaki Okajima; Shinji Uemoto
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

5.  Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.

Authors:  Hisaya Shirai; Toshimi Kaido; Yuhei Hamaguchi; Atsushi Kobayashi; Shinya Okumura; Siyuan Yao; Shintaro Yagi; Naoko Kamo; Kojiro Taura; Hideaki Okajima; Shinji Uemoto
Journal:  Liver Cancer       Date:  2017-12-08       Impact factor: 11.740

Review 6.  Association between Loss of Skeletal Muscle Mass and Mortality and Tumor Recurrence in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ke-Vin Chang; Jin-De Chen; Wei-Ting Wu; Kuo-Chin Huang; Chia-Tzu Hsu; Der-Sheng Han
Journal:  Liver Cancer       Date:  2017-12-09       Impact factor: 11.740

7.  Prognostic value and association of sarcopenic obesity and systemic inflammatory indexes in patients with hepatocellular carcinoma following hepatectomy and the establishment of novel predictive nomograms.

Authors:  Chengyu Liao; Ge Li; Yannan Bai; Songqiang Zhou; Long Huang; Maolin Yan; Funan Qiu; Jiangzhi Chen; Yaodong Wang; Yifeng Tian; Shi Chen
Journal:  J Gastrointest Oncol       Date:  2021-04

8.  Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor.

Authors:  Naoaki Maeda; Yasuhiro Shirakawa; Shunsuke Tanabe; Kazufumi Sakurama; Kazuhiro Noma; Toshiyoshi Fujiwara
Journal:  World J Surg Oncol       Date:  2020-06-26       Impact factor: 2.754

9.  Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.

Authors:  Hitomi Takada; Masayuki Kurosaki; Hiroyuki Nakanishi; Yuka Takahashi; Jun Itakura; Kaoru Tsuchiya; Yutaka Yasui; Nobuharu Tamaki; Kenta Takaura; Yasuyuki Komiyama; Mayu Higuchi; Youhei Kubota; Wann Wang; Mao Okada; Nobuyuki Enomoto; Namiki Izumi
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

10.  Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients.

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Keun Hur; Akira Yamamoto; Chengzeng Yin; Shozo Ide; Takahito Kitajima; Hiroyuki Fujikawa; Hiromi Yasuda; Yuhki Koike; Yoshiki Okita; Junichiro Hiro; Shigeyuki Yoshiyama; Toshimitsu Araki; Chikao Miki; Donald C McMillan; Ajay Goel; Masato Kusunoki
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-03-25       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.